Anti-IL-22RA antibodies and binding partners and methods of using in inflammation

Details for Australian Patent Application No. 2005299809 (hide)

International Classifications

Event Publications

17 May 2007 PCT application entered the National Phase

PCT publication WO2006/047249 Priority application(s): WO2006/047249

5 July 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 20 Apr 2007

6 September 2007 Section 223 Application Received

ZymoGenetics, Inc. An application to extend the time from 03 May 2006 to 03 May 2007 in which to enter the national phase has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2007

1 November 2007 Section 223 Application Allowed

ZymoGenetics, Inc. The time in which to enter the National Phase has been extended to 03 May 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2006 Extensions of Time, Section 223

2 December 2010 Application Accepted

Published as AU-B-2005299809

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.